Genistein alters growth factor signaling by downregulating tyrosine kinase-regulated proteins, epidermal growth factor receptor (EGFR), and IGF-1R in transgenic adenocarcinoma in mouse prostate models [111]. The gene discussed is EGFR; the disease is adenocarcinoma.